• The Harm Reduction Promise of GLP-1s

  • Jan 28 2025
  • Length: 1 hr and 31 mins
  • Podcast

The Harm Reduction Promise of GLP-1s

Listen for free

View show details

  • Summary

  • Could GLP-1s become the next frontier in harm reduction? Clinical researchers have discovered that GLP‑1 drugs like Ozempic and Wegovy not only aid with diabetes and weight loss but may also reduce cravings and enhance satiation for alcohol, tobacco, cannabis, opioids, and possibly other addictive drugs like cocaine and methamphetamine. These exciting developments mean GLP-1s may soon become a new harm-reduction tool and possibly transform the treatment of substance use disorders. Our expert panel will explore the latest findings, their transformative implications for addiction treatment, and policies to improve affordability and access for those who need them.

    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
Show more Show less

What listeners say about The Harm Reduction Promise of GLP-1s

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available